Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
anti-staphylococcus bacteriophage therapy (2 trials)
e. coli phages cocktail (1 trial)
p. aeruginosa phages cocktail (1 trial)
silver sulfadiazine (silvadene) (1 trial)
Communicable Diseases (Phase 2)
Diabetic Foot (Phase 2)
Foot Ulcer (Phase 2)
Infections (Phase 2)
Staphylococcal Infections (Phase 2)
Wound Infection (Phase 2)
Wounds and Injuries (Phase 2)
Trials (3 total)
Trial APIs (4 total)